ABBV vs ASML · P/E 81, rev $61.16B vs P/E 57, $665.37B cap
AbbVie Inc (ABBV) versus ASML Holding NV ADR (ASML) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
ASML does not have a complete income-statement cache yet.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ASML currently screens at market cap $665.37B and trailing P/E 57.5.
Not investment advice. Open the ABBV and ASML stock pages for the full models.
Not investment advice.